Close

AcelRx Pharma (ACRX) Announces Positive Data from ARX-04 Phase 3 in Elderly Patients and Patients with Organ Impairment

Go back to AcelRx Pharma (ACRX) Announces Positive Data from ARX-04 Phase 3 in Elderly Patients and Patients with Organ Impairment